Silence Therapeutics (SLN) Enterprise Value (2018 - 2026)
Silence Therapeutics (SLN) reported Enterprise Value of -$134.5 million for Q1 2026, up 35.37% on a YoY basis from -$99.4 million in Q1 2025, and down 58.05% sequentially from -$85.1 million in Q4 2025.
Silence Therapeutics (SLN) Enterprise Value (2018 - 2026) Analysis & Trends
Silence Therapeutics (SLN) has 9 years of Enterprise Value data on file, last reported at -$134.5 million in Q1 2026.
- For the quarter ending Q1 2026, Enterprise Value rose 35.37% year-over-year to -$134.5 million; the trailing twelve-month figure through Mar 2026 stood at -$134.5 million (up 35.37% YoY), and the FY2025 full-year result was -$85.1 million, up 54.26% from the prior year.
- Enterprise Value declined to -$134.5 million in Q1 2026, from -$85.1 million in the prior quarter.
- In the past five years, Enterprise Value ranged from a high of -$64.3 million in Q4 2022 to a low of -$208.1 million in Q1 2025.
- A 5-year average of -$122.7 million and a median of -$118.3 million in 2025 frame the typical range for Enterprise Value.
- Across the five-year window, Enterprise Value plunged 177.47% in 2024 and soared 54.26% in 2025, its largest moves.
- Tracing SLN's Enterprise Value over 5 years: stood at -$64.3 million in 2022, then declined by 4.3% to -$67.1 million in 2023, then sank by 177.47% to -$186.1 million in 2024, then soared by 54.26% to -$85.1 million in 2025, then tumbled by 58.05% to -$134.5 million in 2026.
- Business Quant data shows SLN's Enterprise Value at -$134.5 million in Q1 2026, -$85.1 million in Q4 2025, and -$122.4 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Enterprise Value (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | -283.54 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | -61.40 Mn |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | -4.79 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | -32.26 Mn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | -7.25 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | -8.75 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | -5.18 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | -1.91 Bn |
| 10 | Silence Therapeutics | 1.62 Bn | 1.49 Bn | 411,000.00 | -134.52 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -134.52 Mn |
| Dec 31, 2025 | -85.11 Mn |
| Sep 30, 2025 | -122.36 Mn |
| Jun 30, 2025 | -114.16 Mn |
| Mar 31, 2025 | -208.15 Mn |
| Dec 31, 2024 | -186.07 Mn |
| Dec 31, 2023 | -67.06 Mn |
| Dec 31, 2022 | -64.30 Mn |
| Dec 31, 2021 | -99.13 Mn |
| Dec 31, 2020 | -38.22 Mn |
| Dec 31, 2019 | -17.38 Mn |
| Dec 31, 2018 | -27.66 Mn |